Latest Articles

Publication Date
Endometrial Cancer Market Growth, Trends, and Key Players 2025 | Eisai Co., Ltd., ARIAD Pharmaceuticals, Novartis. - openPR

Endometrial Cancer Market Growth, Trends, and Key Players 2025 | Eisai Co., Ltd., ARIAD Pharmaceuticals, Novartis. openPR

Published: Jan. 23, 2025, 6:14 a.m.
GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer - MSN

GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer MSN

Published: Jan. 23, 2025, 12:35 a.m.
Exploring Microbial Signatures in Endometrial Tissues with Endometriosis.

The endometrial microbiota exerts a crucial role in maintaining the health of the female reproductive system. As such, in this study, we have examined the composition of the microbiota in …

Published: Jan. 23, 2025, midnight
Biosynthetic pathway for leukotrienes is stimulated by lipopolysaccharide and cytokines in pig endometrial stromal cells - Nature.com

Biosynthetic pathway for leukotrienes is stimulated by lipopolysaccharide and cytokines in pig endometrial stromal cells Nature.com

Published: Jan. 22, 2025, 11:41 a.m.
Cervical Anatomical Characteristics in Women with Endometriosis: A Diagnostic Approach.

Endometriosis is a gynecologic disorder which causes dysmenorrhea and infertility. Early diagnosis of endometriosis can help prevent the necessity for invasive diagnostic procedures. Medical imaging has been widely utilized to …

Published: Jan. 22, 2025, midnight
Your period and your pregnancy, a cohort study of pregnant patients investigating the associations between menstruation and birth outcomes in Australia: study protocol.

Early pregnancy care involves the screening and identification of women with risk factors for adverse pregnancy outcomes, including stillbirth or preterm birth, to tailor pregnancy care and interventions accordingly. Most …

Published: Jan. 22, 2025, midnight
Cost-Effectiveness Of Durvalumab For Endometrial Cancer Uncovered - Evrim Ağacı

Cost-Effectiveness Of Durvalumab For Endometrial Cancer Uncovered Evrim Ağacı

Published: Jan. 21, 2025, 9:50 p.m.
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer - AOL

Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer AOL

Published: Jan. 21, 2025, 9:14 p.m.
GSK gets expanded EU approval for Jemperli in endometrial cancer - MSN

GSK gets expanded EU approval for Jemperli in endometrial cancer MSN

Published: Jan. 21, 2025, 7:31 p.m.
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer - Yahoo Finance

Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer Yahoo Finance

Published: Jan. 21, 2025, 6:43 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!